Nuformix PLC (NFX)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.25p
Buy
0.28p
0.055p (+26.19%)
Prices updated at 12 Dec 2025, 16:30 GMT
| Prices minimum 15 mins delay
Prices in GBX
Nuformix PLC is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
28 Nov 202512 Nov 202512 Nov 202528 Oct 202510 Oct 202525 Sep 202511 Aug 202530 May 202529 May 202523 May 2025
Key dates
| Forecast date | |
|---|---|
| Half yearly results | May 2026 |
| Annual general meeting | Mar 2026 |
| Annual report | Feb 2026 |
| Final results | Jan 2026 |
| Previous date | |
|---|---|
| Half yearly results | May 2025 |
| Annual general meeting | Mar 2025 |
| Annual report | Feb 2025 |
| Final results | Jan 2025 |
Company reports
30 Sep 2023
Annual Report 31 Dec 2015
Quarterly Report 